Progesterone for prevention of recurrent preterm labor after threatened preterm labor -A randomized controlled trial

Introduction Preterm birth is the major cause of neonatal mortality and morbidity. In addition, prematurity is strongly associated with long-term developmental disabilities, accounting for 1 in 5 children with mental retardation, 1 in 3 children with vision impairment, and almost half of children w...

全面介紹

Saved in:
書目詳細資料
主要作者: Uprety, Prof. Dr. Dhruba
格式: Technical Report
語言:en_US
出版: 2012
主題:
在線閱讀:http://103.69.126.140:8080/handle/123456789/693
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:Introduction Preterm birth is the major cause of neonatal mortality and morbidity. In addition, prematurity is strongly associated with long-term developmental disabilities, accounting for 1 in 5 children with mental retardation, 1 in 3 children with vision impairment, and almost half of children with cerebral palsy. So, prevention of preterm birth is a public health priority. Methods A randomized controlled trial was undertaken in BP Koirala Institute of Health Sciences, where 60 patients were randomized into group 1 (n=29, weekly intramuscular Progesterone) and group 2 ( n=31,no treatment) after the arrest of preterm labor with tocolysis. Their latency period till delivery and recurrence of preterm labor and neonatal outcomes were compared. Results There was significant reduction in recurrence of preterm labor and increase in latency period in progesterone group. However neonatal outcomes were similar. Conclusion Progesterone is useful in reducing the recurrence of preterm labor in a patient who had preterm labor.